---
title: "Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281016463.md"
description: "Hangzhou Tigermed Consulting Co., Ltd reported its earnings for the full year ended December 31, 2025. The company achieved sales of CNY 6,832.8 million, up from CNY 6,603.12 million the previous year. Net income rose to CNY 887.89 million, compared to CNY 405.14 million a year earlier. Basic and diluted earnings per share from continuing operations were both CNY 1.04, an increase from CNY 0.47 in the prior year."
datetime: "2026-03-30T12:08:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281016463.md)
  - [en](https://longbridge.com/en/news/281016463.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281016463.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281016463.md) | [繁體中文](https://longbridge.com/zh-HK/news/281016463.md)


# Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2025

Hangzhou Tigermed Consulting Co., Ltd reported earnings results for the full year ended December 31, 2025. For the full year, the company reported sales was CNY 6,832.8 million compared to CNY 6,603.12 million a year ago. Revenue was CNY 6,832.8 million compared to CNY 6,603.12 million a year ago.

Net income was CNY 887.89 million compared to CNY 405.14 million a year ago. Basic earnings per share from continuing operations was CNY 1.04 compared to CNY 0.47 a year ago. Diluted earnings per share from continuing operations was CNY 1.04 compared to CNY 0.47 a year ago.

### Related Stocks

- [Tigermed (300347.CN)](https://longbridge.com/en/quote/300347.CN.md)
- [TIGERMED (03347.HK)](https://longbridge.com/en/quote/03347.HK.md)

## Related News & Research

- [Tigermed Projects Over 50% Surge in 2025 Net Profit](https://longbridge.com/en/news/274150967.md)
- [Guan Chao's Loss Balloons in 2025](https://longbridge.com/en/news/281314987.md)
- [Here's What to Expect From CBRE Group's Next Earnings Report](https://longbridge.com/en/news/281323999.md)
- [Assessing CALB Group (SEHK:3931) Valuation After Strong 2025 Earnings And Share Price Momentum](https://longbridge.com/en/news/281668705.md)
- [Wipro Sets Board Meet to Approve FY26 Results, Closes Trading Window](https://longbridge.com/en/news/281530627.md)